Schedule 13D ownership disclosure

DOGWOOD THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 92829J203

Event date: 2025-11-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sealbond LimitedReported CIK 0002040446

    Shares: 21,822,333.00 · Class: 73.4%

  • CK Life Sciences Int'l., (Holdings) Inc.

    Shares: 24,664,971.00 · Class: 83.0%

  • Conjoint Inc.

    Shares: 2,842,638.00 · Class: 9.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-116057
Form type
SCHEDULE 13D/A
Filer
Dogwood Therapeutics, Inc.
CIK
CIK 1818844
Filed
Nov 25, 2025
Reporting period
Nov 21, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub